A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 2601
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : SARS
Long Form : severe acute respiratory syndrome
No. Year Title Co-occurring Abbreviation
2019 Bats and Coronaviruses. CoVs, MERS, PED, SADS
2019 Construction and next-generation sequencing analysis of a large phage-displayed VNAR single-domain antibody library from six naive nurse sharks. CDR, HER2, MERS, PCR, PD1, VNAR
2019 Customs officers in relation to viral infections, tuberculosis, psittacosis and environmental health risk. ---
2019 Development of Competencies for Respiratory Protection for Health Care Workers. ---
2019 Epidemic Models of Contact Tracing: Systematic Review of Transmission Studies of Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. MERS
2019 Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor. ---
2019 Factors Influencing the Response to Infectious Diseases: Focusing on the Case of SARS and MERS in South Korea. MERS
2018 A Comparison of China's Risk Communication in Response to SARS and H7N9 Using Principles Drawn From International Practice. ---
2018 A disaster diplomacy perspective of acute public health events. ---
10  2018 A Mini Review of the Zoonotic Threat Potential of Influenza Viruses, Coronaviruses, Adenoviruses, and Enteroviruses. ---
11  2018 A Systematic, Thematic Review of Social and Occupational Factors Associated With Psychological Outcomes in Healthcare Employees During an Infectious Disease Outbreak. ---
12  2018 Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections. PTGS, RSV, siRNA
13  2018 An overview of the National Microbiology Laboratory emergency management program. ICS, ISO, NML
14  2018 Beneficial effects of Houttuynia cordata polysaccharides on "two-hit" acute lung injury and endotoxic fever in rats associated with anti-complementary activities. ALI, BALF, CHCP, LPS
15  2018 Clinical Pearls in Venovenous Extracorporeal Life Support for Adult Respiratory Failure. ARDS, ECLS, ELSO, MERS-CoV
16  2018 Conservation implications of primate trade in China over 18 years based on web news reports of confiscations. ---
17  2018 Current discovery progress of some emerging anti-infective chalcones: Highlights from 2016 to 2017. HIV, TMV
18  2018 Design of novel multi-epitope vaccines against Severe Acute respiratory syndrome validated through multistage molecular interaction and dynamics. CTL, HTL, MEVs, SARS-CoV
19  2018 Development of an efficient viral aerosol collector for higher sampling flow rate. AGI-30, SJAC
20  2018 Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. SADS-CoV
21  2018 Fifteen years post-SARS: Key milestones in Canada's public health emergency response. FPT
22  2018 Genetic Characteristics of Coronaviruses from Korean Bats in 2016. RdRp
23  2018 Host Factors in Coronavirus Replication. MERS
24  2018 Human metapneumovirus in Southern Brazil. EWs, hMPV, HRSV, NP
25  2018 MERS, SARS and other coronaviruses as causes of pneumonia. CoV, HCoVs, MERS
26  2018 Middle East respiratory syndrome coronavirus (MERS-CoV): Impact on Saudi Arabia, 2015. MERS-CoV
27  2018 Rebooting Bioresilience: A Multi-OMICS Approach to Tackle Global Catastrophic Biological Risks and Next-Generation Biothreats. GCBRs
28  2018 Routes of transmission of influenza A H1N1, SARS CoV, and norovirus in air cabin: Comparative analyses. CI, CoV, RR, RR
29  2018 SARS-Like Coronavirus WIV1-CoV Does Not Replicate in Egyptian Fruit Bats (Rousettus aegyptiacus). ACE2, CoV
30  2018 Securitizing HIV/AIDS: a game changer in state-societal relations in China? HIV/AIDS, IR, NGOs, SDGs, UNSC
31  2018 Strategic decision making about travel during disease outbreaks: a game theoretical approach. ---
32  2018 Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA. CoVs, ExoN, MTase
33  2018 Structural insights of a self-assembling 9-residue peptide from the C-terminal tail of the SARS corona virus E-protein in DPC and SDS micelles: A combined high and low resolution spectroscopic study. CoV
34  2018 Studying Communication Problems for Emergency Management of SARS and H7N9 in China. ---
35  2018 Survival of the Enveloped Virus Phi6 in Droplets as a Function of Relative Humidity, Absolute Humidity, and Temperature. AH, MERS, RH
36  2018 The coronavirus nucleocapsid protein is ADP-ribosylated. CoV, MERS, MHV, PEDV, VRPs
37  2018 The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. MERS
38  2018 Tracking Nosocomial Diseases at Individual Level with a Real-Time Indoor Positioning System. HAIs
39  2018 Transcriptional and Translational Landscape of Equine Torovirus. EToV, ORFs, sgRNAs
40  2018 Ventilation control for airborne transmission of human exhaled bio-aerosols in buildings. MERS
41  2017 A 12-year follow-up study of combined treatment of post-severe acute respiratory syndrome patients with femoral head necrosis. ARCO, ONFH, VAS
42  2017 A novel Coltivirus-related virus isolated from free-tailed bats from Cote d'Ivoire is able to infect human cells in vitro. MERS
43  2017 An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus. CoV, MERS
44  2017 Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry. HCoV-229E, MERS, TMPRSS2
45  2017 Comparing nonpharmaceutical interventions for containing emerging epidemics. ---
46  2017 Discovery and genetic analysis of novel coronaviruses in least horseshoe bats in southwestern China. CoVs, ORFs
47  2017 Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study. CoMFA, Mpro, SARS-CoV
48  2017 Effectiveness of Masks and Respirators Against Respiratory Infections in Healthcare Workers: A Systematic Review and Meta-Analysis. CI, CRI, ILI, RCTs, RR
49  2017 Emerging infectious diseases: prediction and detection. EIDs
50  2017 Epidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome). CoVs, MERS
51  2017 Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study. ---
52  2017 Establishment and Application of a Universal Coronavirus Screening Method Using MALDI-TOF Mass Spectrometry. HCoVs, MALDI-TOF MS, MERS
53  2017 Everyday Dangers - The Impact Infectious Disease has on the Health of Paramedics: A Scoping Review. HIV, MRSA
54  2017 Federal travel restrictions to prevent disease transmission in the United States: An analysis of requested travel restrictions. PHTR, TB
55  2017 Fluorescent Inhibitors as Tools To Characterize Enzymes: Case Study of the Lipid Kinase Phosphatidylinositol 4-Kinase IIIbeta (PI4KB). FLIM, HCV, PI4KB
56  2017 Genetic diversity of coronaviruses in bats in Lao PDR and Cambodia. alphaCoV, CoVs
57  2017 Group A Rotaviruses in Chinese Bats: Genetic Composition, Serology, and Evidence for Bat-to-Human Transmission and Reassortment. IIFA, MERS, RT-PCR, RVAs
58  2017 Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies. MERS
59  2017 Molecular Dynamic Studies of Interferon and Innate Immunity Resistance in MERS CoV Non-Structural Protein 3. IFN, MERS CoV, nsP3, RMSD, UBL
60  2017 Monoclonal Antibodies and Antibody Like Fragments Derived from Immunised Phage Display Libraries. ---
61  2017 Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion. ADAM, CoV, MERS, MHV, MMP
62  2017 No. 225-Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS). ---
63  2017 Novel Alphacoronaviruses and Paramyxoviruses Cocirculate with Type 1 and Severe Acute Respiratory System (SARS)-Related Betacoronaviruses in Synanthropic Bats of Luxembourg. ---
64  2017 Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate. RBD
65  2017 Pathogen genomic surveillance elucidates the origins, transmission and evolution of emerging viral agents in China. MERS, ZIKV
66  2017 Polyadenine-Modulated DNA Conformation Monitored by Surface-Enhanced Raman Scattering (SERS) on Multibranched Gold Nanoparticles and Its Sensing Application. polyA, SERS
67  2017 Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong. ---
68  2017 SARS-unique fold in the Rousettus bat coronavirus HKU9. nsP3
69  2017 Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection. CoVs
70  2017 Simultaneous detection of severe acute respiratory syndrome, Middle East respiratory syndrome, and related bat coronaviruses by real-time reverse transcription PCR. CoVs, MERS, RT
71  2017 Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis. CI, RR
72  2017 Strategy and technology to prevent hospital-acquired infections: Lessons from SARS, Ebola, and MERS in Asia and West Africa. HAIs, MERS
73  2017 Structural basis for dimerization and RNA binding of avian infectious bronchitis virus nsp9. CoVs, IBV, NSPs
74  2017 Structural Biology of the Arterivirus nsp11 Endoribonucleases. CoV, CTD, EAV, MERS, nsp11, NTD, PRRSV
75  2017 T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV. MERS, MERS-CoV, SARS-CoV
76  2017 The Middle East Respiratory Syndrome Coronavirus - A Continuing Risk to Global Health Security. EC, MERS, MERS-CoV, SARS-CoV, WHO
77  2017 The nucleocapsid proteins of mouse hepatitis virus and severe acute respiratory syndrome coronavirus share the same IFN-beta antagonizing mechanism: attenuation of PACT-mediated RIG-I/ MDA5 activation. CoVs, IFNs, MDA5, MHV, PACT, PEDV, PRRSV, RIG-I
78  2017 The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. EGFR, MERS, SARS-CoV
79  2017 The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination. IFN, MERS-CoV, N protein, RIG-I, SeV, TRIM25
80  2016 A molecular arms race between host innate antiviral response and emerging human coronaviruses. MERS
81  2016 An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy. SARS-CoV, SARS-CoV
82  2016 Analysis of Spatiotemporal Characteristics of Pandemic SARS Spread in Mainland China. BME
83  2016 Antigen Production in Plant to Tackle Infectious Diseases Flare Up: The Case of SARS. SARS-CoV
84  2016 Automatically quantifying the scientific quality and sensationalism of news records mentioning pandemics: validating a maximum entropy machine-learning model. ---
85  2016 Avoiding Regions Symptomatic of Conformational and Functional Flexibility to Identify Antiviral Targets in Current and Future Coronaviruses. MERS, NSP
86  2016 Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response. GFP, ORF, SL-CoVs
87  2016 Coexistence of multiple coronaviruses in several bat colonies in an abandoned mineshaft. RdRp
88  2016 Comparative Epidemiology of Human Infections with Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome Coronaviruses among Healthcare Personnel. CFR, HCP, MERS, MERS-CoV
89  2016 Coping with future epidemics: Tai chi practice as an overcoming strategy used by survivors of severe acute respiratory syndrome (SARS) in post-SARS Hong Kong. CAM
90  2016 Coronavirus Spike Protein and Tropism Changes. CoVs, MERS
91  2016 Coronaviruses - drug discovery and therapeutic options. HCoV, MERS
92  2016 Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors. CoVs, FIP, FIPV, MERS, pro, pro
93  2016 Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant. ---
94  2016 Distribution and Evolutionary History of the Mobile Genetic Element s2m in Coronaviruses. ---
95  2016 Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. IFNAR, IMMs
96  2016 Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. HCoVs, MERS
97  2016 Genomics and zoonotic infections: Middle East respiratory syndrome. MERS, MERS-CoV
98  2016 Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). MERS, MERS-CoV, SARS-CoV
99  2016 Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors. NA
100  2016 Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates. ADE, ESD